Review
Noninvasive tests for liver disease, fibrosis, and cirrhosis: Is liver biopsy obsolete?
Emily Carey, DO and William D. Carey, MD
Cleveland Clinic Journal of Medicine August 2010, 77 (8) 519-527; DOI: https://doi.org/10.3949/ccjm.77a.09138
Emily Carey
Digestive Disease Institute, Cleveland Clinic
William D. Carey
Transplant Center and Digestive Disease Institute, Cleveland Clinic; Director, Center for Continuing Education; Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
In this issue
Cleveland Clinic Journal of Medicine
Vol. 77, Issue 8
1 Aug 2010
Noninvasive tests for liver disease, fibrosis, and cirrhosis: Is liver biopsy obsolete?
Emily Carey, William D. Carey
Cleveland Clinic Journal of Medicine Aug 2010, 77 (8) 519-527; DOI: 10.3949/ccjm.77a.09138
Jump to section
Related Articles
- No related articles found.
Cited By...
- Serologic biomarkers and scoring systems for hepatic fibrosis in obese children with nonalcoholic steatohepatitis
- Audit of medical (non-targeted) liver biopsy specimen quality, pathology reporting and effect on patient management
- Serum metabolite profiles are associated with the presence of advanced liver fibrosis in Chinese patients with chronic hepatitis B viral infection